6-K

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

For the month of March 2007

Commission File Number 000-20181

Sapiens International Corporation N.V.
(translation of registrant’s name into English)

c/o Landhuis Joonchi
Kaya Richard J. Beaujon z/n
P.O. Box 837
Willemstad
Curacao, Netherlands Antilles
(599) (9) 7366277

(address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934

Yes o No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.




SAPIENS ANNOUNCES Q4 2006 AND YEAR-END RESULTS
Reports Initial Success of its Turnaround Program as the
Company Returns to Operational Profit in Fourth Quarter

Cary, N.C. – March 1, 2007 – Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a member of the Formula Group (NASDAQ: FORTY and TASE: FORT) that was recently acquired by Emblaze Ltd (LSE: BLZ.L) announces today its results of operations for the year ended December 31, 2006 and for the fourth quarter of 2006.

Financial Highlights
  Annual Revenues increased 12.4% to $44.3 million for 2006, up from $39.4 million for 2005

  Q4 Revenues increased 14.3% to $11.2 million, up from $9.8 million in Q4 2005

  Operating Loss for the year significantly declined by 76.4% to $1.3 million, down from $5.5 million in 2005

  The Company achieved an Operational Profit of $0.08 million in Q4 2006, compared with an Operational Loss of $0.96 million in Q4 2005

  Significant reduction in Annual Net Loss by 58.2% to $3.8 million, down from $9.1 million in 2005

  Significant reduction in Q4 Net Loss by 75.2% to $0.77 million, down from $3.1 million in Q4 2005

Operational Highlights
  The Company sees the initial success of its turnaround plan
  Return to operational profit
  Continued focus on solutions for the global insurance industry
  Further enhancements of Sapiens’ core technology, eMerge™, to maintain the Company’s competitive edge in the insurance IT management systems market
  Sapiens continues to pursue its long term vision of becoming the de-facto industry standard

Roni Al-Dor, President and CEO, commented “Sapiens today is a real global player with major corporate customers in many countries. We still have a long way to go for full recovery but I continue to be encouraged about our progress and improvements. We will maintain focus on increasing revenue and profitability while controlling our costs and improving our sales and marketing efforts. I am certain our employees and management will continue to deliver results and will successfully complete the turnaround plan over the next two years.”

[Tables Follow]



FOR ADDITIONAL INFORMATION:
  Elior Brin Roni Al-Dor
  Chief Financial Officer Chief Executive Officer
  Sapiens International Sapiens International
  Tel: +972-8-938-2721 Tel: +972-8-938-2721
  E-mail: IR.Sapiens@sapiens.com E-mail: IR.Sapiens@sapiens.com

About Sapiens International

Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of Formula Group (Nasdaq: FORTY and TASE: FORT), is a leading global provider of proven IT solutions that modernize business processes and enable insurance organizations to adapt quickly to change. Sapiens’ innovative solutions are widely recognized for their ability to cost-effectively align IT with the business demands for speed, flexibility and efficiency. Sapiens operates through its subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific, and has partnerships with market leaders such as IBM and EDS. Sapiens’ clients include AXA, Liverpool Victoria, Norwich Union, OneBeacon, Principal Financial Group, Prudential, ING, Menora and Occidental Fire & Casualty among others. For more information, please visit http://www.sapiens.com.

Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of the Company’s accounting policies, specific system configurations and software needs of individual customers and other risk factors detailed in the Company’s SEC filings.



SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Balance Sheets
(U.S. Dollars in thousands)

3/31/2006
6/30/2006
9/30/2006
12/31/2006
31/12/2005
(Corrected)
 
 
 
 
Unaudited (*)
Unaudited
Unaudited
Unaudited
Audited
 
Assets                        
   
          Cash and cash equivalents   $ 6,016   $ 4,332   $ 4,783   $ 3,108   $ 6,699  
          Short-term investments    5,110    4,304    499    32    5,337  
          Trade receivables, net    10,428    13,283    11,983    11,010    8,339  
          Other current assets    2,107    2,198    2,044    1,857    1,520  





          Total current assets     23,661    24,117    19,309    16,007    21,895  





   
          Property and equipment, net    1,631    1,666    1,562    1,495    1,716  
          Other assets, net    28,027    28,495    28,710    28,117    28,255  





Total assets    $ 53,319   $ 54,278   $ 49,581   $ 45,619   $ 51,866  





   
Liabilities and shareholders' equity   
 
          Short-term bank credit and current maturities  
             of long-term debt and convertible debentures   $ 20,551   $ 19,077   $ 11,666   $ 15,603   $ 19,112  
          Trade payables    2,780    3,105    2,305    2,019    1,910  
          Other liabilities and accrued expenses    8,085    8,286    8,608    7,370    6,742  
          Deferred revenue    4,467    5,197    4,464    3,463    4,867  





          Total current liabilities     35,883    35,665    27,043    28,455    32,631  





   
          Long-term debt and other long-term liabilities    1,630    2,796    1,874    1,439    1,584  
          Convertible debentures and warrants    14,087    14,167    16,345    11,796    14,019  
          Shareholders' equity    1,719    1,650    4,319    3,929    3,632  





Total liabilities and shareholders' equity    $ 53,319   $ 54,278   $ 49,581   $ 45,619   $ 51,866  






Note: Certain prior quarter/year amounts have been reclassified to conform with the current year presentation.
(*) See Note (d) to the Condensed Consolidated Statements of Income.



SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Statements of Income
(U.S. Dollars in thousands, except per share amounts)

For the three months ended
For the year ended
3/31/2006
6/30/2006
9/30/2006
12/31/2006
12/31/2005
12/31/2006
12/31/2005
(Corrected)(d)
 
 
 
 
 
 
Unaudited
Unaudited
Unaudited
Unaudited
Unaudited
Unaudited
Audited
 
Revenues (a)                                
Products   $ 2,723   $ 3,128   $ 2,179   $ 2,393   $ 3,547   $ 10,423   $ 13,295  
Consulting and other services    7,409    8,536    9,123    8,820    6,224    33,888    26,109  







Total revenues    10,132    11,664    11,302    11,213    9,771    44,311    39,404  







   
Cost of revenues (a)   
Products    2,613    2,541    2,417    2,223    3,041    9,794    11,306  
Consulting and other services    3,917    5,141    4,853    5,096    3,226    19,007    13,540  







Total cost of revenues    6,530    7,682    7,270    7,319    6,267    28,801    24,846  







   
Gross Profit     3,602    3,982    4,032    3,894    3,504    15,510    14,558  
   
Operating expenses   
Research and development, net    726    560    682    483    480    2,451    2,723  
Selling, marketing, general and administrative    3,391    3,378    3,535    3,254    3,987    13,558    16,245  
Restructuring expenses    635    21    25    77    -    758    1,113  







   
Operating Income (Loss)     (1,150 )  23    (210 )  80    (963 )  (1,257 )  (5,523 )
   
Financial expenses, net    575    639    372    644    407    2,230    1,788  
Other expenses, net (b)    53    41    41    203    1,747    338    1,788  







   
Net Loss    $ (1,778 ) $ (657 ) $ (623 ) $ (767 ) $ (3,117 ) $ (3,825 ) $ (9,099 )







   
Basic and diluted loss per share (c)   $ 0.12   $ 0.05   $ 0.05   $ 0.05   $ 0.25   $ 0.29   $ 0.76  







Weighted average shares used to compute -  
                  basic and diluted loss per share (c)    14,854    12,510    13,707    14,854    12,492    13,395    11,982  

Notes: a: Certain prior quarter/year amounts have been reclassified to conform with the current year presentation.
  b: Includes taxes and minority interest.
  c: Due to the net loss in 2005 and 2006, the inclusion of dilutive securities would be antidilutive.
  d: The Company corrected its results for the first quarter of 2006, by (i) reducing revenues for the quarter by $345 thousand, as a result of the reversal of revenues recognized, (ii) increasing general and administrative expenses for the quarter by $86 thousand, related to bad debt from one of the Company’s customers, thereby increasing the operating loss and net loss for the first quarter by $431 thousand. In parallel, the Company reduced its trade receivables for the first quarter by $450 thousand.



SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.




Date: March 1, 2007
Sapiens International Corporation N.V.
(Registrant)

By: /s/ Andrew Treitel
——————————————
Andrew Treitel
General Counsel and Corporate Secretary